These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 22381427

  • 1. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
    Zhang L, Lu Y, Jiang H, Zhang L, Sun A, Zou Y, Ge J.
    J Am Coll Cardiol; 2012 Mar 06; 59(10):913-22. PubMed ID: 22381427
    [Abstract] [Full Text] [Related]

  • 2. Is treatment with trimetazidine beneficial in patients with chronic heart failure?
    Zhou X, Chen J.
    PLoS One; 2014 Mar 06; 9(5):e94660. PubMed ID: 24797235
    [Abstract] [Full Text] [Related]

  • 3. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials.
    Xin W, Wei W, Li X.
    Heart; 2012 Nov 06; 98(22):1620-5. PubMed ID: 22760864
    [Abstract] [Full Text] [Related]

  • 4. Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.
    Hu LJ, Chen YQ, Deng SB, Du JL, She Q.
    Br J Clin Pharmacol; 2013 May 06; 75(5):1202-12. PubMed ID: 23088367
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 06; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 6. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 06; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 8. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 05; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 9. Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials.
    Zhang L, Zhang S, Jiang H, Sun A, Zou Y, Ge J.
    Clin Cardiol; 2011 Feb 05; 34(2):117-23. PubMed ID: 21298656
    [Abstract] [Full Text] [Related]

  • 10. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D, Ning N, Niu X, Hao G, Meng Z.
    Heart; 2011 Feb 05; 97(4):278-86. PubMed ID: 21134903
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure.
    Liang Y, Pan W, Su Y, Ge J.
    Am J Cardiol; 2011 Oct 15; 108(8):1160-5. PubMed ID: 21813108
    [Abstract] [Full Text] [Related]

  • 12. Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis.
    Zhao Y, Peng L, Luo Y, Li S, Zheng Z, Dong R, Zhu J, Liu J.
    Herz; 2016 Sep 15; 41(6):514-22. PubMed ID: 26668006
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis.
    Zhang S, Zhang L, Sun A, Jiang H, Qian J, Ge J.
    Eur J Intern Med; 2011 Oct 15; 22(5):478-84. PubMed ID: 21925056
    [Abstract] [Full Text] [Related]

  • 14. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 15; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 15. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.
    Heart; 2011 Sep 15; 97(18):1495-500. PubMed ID: 21700755
    [Abstract] [Full Text] [Related]

  • 16. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 17. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov 28; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 18. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004 Nov 28; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 19. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
    Fragasso G, Rosano G, Baek SH, Sisakian H, Di Napoli P, Alberti L, Calori G, Kang SM, Sahakyan L, Sanosyan A, Vitale C, Marazzi G, Margonato A, Belardinelli R.
    Int J Cardiol; 2013 Mar 10; 163(3):320-325. PubMed ID: 23073279
    [Abstract] [Full Text] [Related]

  • 20. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 10; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.